Rocket Pharmaceuticals Inc (NASDAQ: RCKT) established initial surge of 2.44% at $3.78, as the Stock market unbolted on Thursday, before settling in for the price of $3.69 at the close. Taking a more long-term approach, RCKT posted a 52-week range of $2.19-$11.45.
It was noted that the giant of the Healthcare sector posted annual sales growth of -11.60% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -11.60%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 24.90%. This publicly-traded company’s shares outstanding now amounts to $108.21 million, simultaneously with a float of $99.69 million. The organization now has a market capitalization sitting at $409.08 million.
Rocket Pharmaceuticals Inc (RCKT) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Rocket Pharmaceuticals Inc industry. Rocket Pharmaceuticals Inc’s current insider ownership accounts for 7.89%, in contrast to 86.13% institutional ownership. According to the most recent insider trade that took place on Jan 02 ’26, this organization’s Director bought 10,000 shares at the rate of 3.44, making the entire transaction reach 34,400 in total value, affecting insider ownership by 50,000. Preceding that transaction, on Nov 18 ’25, Company’s insider sold 2,545 for 2.98, making the whole transaction’s value amount to 7,592. This particular insider is now the holder of 299,064 in total.
Rocket Pharmaceuticals Inc (RCKT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
Rocket Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 24.90% and is forecasted to reach -1.56 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 21.89% through the next 5 years, which can be compared against the -11.60% growth it accomplished over the previous five years trading on the market.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Trading Performance Indicators
Let’s observe the current performance indicators for Rocket Pharmaceuticals Inc (RCKT). It’s Quick Ratio in the last reported quarter now stands at 7.30.
In the same vein, RCKT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.25, a figure that is expected to reach -0.43 in the next quarter, and analysts are predicting that it will be -1.56 at the market close of one year from today.
